Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/10/2012US20120114599 Opioid and opioid-like compounds and uses thereof
05/10/2012US20120114598 IL-1alpha immunization induces autoantibodies protective against atherosclerosis
05/10/2012US20120114597 Cd4+cd25- t cells and tr1-like regulatory t cells
05/10/2012US20120114596 Tslp promotes immune evasion and persistence of viruses
05/10/2012US20120114595 Sugar chain-added ailim extracellular domain and method for producing same
05/10/2012US20120114594 Muscle repair promoter
05/10/2012US20120114593 Method and composition for altering a b cell mediated pathology
05/10/2012US20120114590 Il28 and il29 truncated cysteine mutants and antiviral methods of using same
05/10/2012US20120114588 Ibat inhibitors for treatment of metabolic disorders and related conditions
05/10/2012US20120114577 Peptide Having Activity of Transforming Growth Factor and Production Method Therefor
05/10/2012US20120114570 Collagen extraction from aquatic animals
05/10/2012US20120114565 Compounds modulators of vegf activity and uses thereof
05/10/2012US20120114562 Method for treating pervasive development disorders
05/10/2012US20120114561 Methods for the treatment of neurodegenerative disorders
05/10/2012US20120114558 Aptamer-mediated drug release
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012US20120111324 Dry Powder Drug Delivery Formulations, Methods of Use, and Devices Therefore
05/10/2012CA2854437A1 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
05/10/2012CA2816818A1 Skin wound healing compositions and methods of use thereof
05/10/2012CA2816575A1 A new variant of antihemophilic factor viii having increased specific activity
05/10/2012CA2816529A1 Immune-modulating agents and uses therefor
05/10/2012CA2816114A1 Novel composition comprising glucagon
05/10/2012CA2814704A1 Methods and vectors for cell immortalisation
05/09/2012EP2450442A1 Compositions and methods of using chondroitinase abci mutants
05/09/2012EP2450440A1 Fibrinogenolytic enzyme tabfiblysin of horsefly, tabanus yao, encoding gene and use thereof
05/09/2012EP2450392A1 Polyionic dendrimer and hydrogel comprising same
05/09/2012EP2450374A1 Peptide and use thereof
05/09/2012EP2450373A2 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
05/09/2012EP2450372A1 Regulatory t cell epitopes, compositions and uses thereof
05/09/2012EP2450371A1 Regulatory t cell epitopes, compositions and uses thereof
05/09/2012EP2450370A1 Regulatory t cell epitopes, compositions and uses thereof
05/09/2012EP2450369A1 Regulatory t cell epitopes, compositions and uses thereof
05/09/2012EP2450368A1 Regulatory t cell epitopes, compositions and uses thereof
05/09/2012EP2450367A1 Regulatory t cell epitopes, compositions and uses thereof
05/09/2012EP2450366A1 Regulatory t cell epitopes, compositions and uses thereof
05/09/2012EP2450365A1 T-cell death-inducing epitopes
05/09/2012EP2450056A1 Prevention and treatment of synucleinopathic and amyloidogenic disease
05/09/2012EP2450051A1 Medicinal agent and method for treatment of intractable chronic hepatitis c
05/09/2012EP2450050A1 IL-17A/F heterodimeric polypeptides and therapeutic uses thereof
05/09/2012EP2450049A1 Romidepsin-based treatments for cancer
05/09/2012EP2450048A2 Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
05/09/2012EP2450037A1 Methods, compositions and articles of manufacture for contributing to the treatment of cancers
05/09/2012EP2449102A2 Arginase formulations and methods
05/09/2012EP2449101A1 Neurotoxins exhibiting shortened biological activity
05/09/2012EP2449098A1 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
05/09/2012EP2448968A1 N-terminal truncated amyloid beta protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's disease
05/09/2012EP2448958A1 Human milk peptides
05/09/2012EP2448594A1 Dermaseptin b2 used as an inhibitor of the growth of a tumor
05/09/2012EP2448593A2 Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means
05/09/2012EP2448592A1 Vaccines and compositions against streptococcus pneumoniae
05/09/2012EP2448568A1 Improved formulation for nonsurgical exogenous crosslink therapy
05/09/2012EP2303916B1 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles
05/09/2012EP2297195B9 Antibacterial peptides
05/09/2012EP2293807B1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia
05/09/2012EP2245150B1 Protease for wound conditioning and skin care
05/09/2012EP1740202B1 Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
05/09/2012EP1660686B1 Hpv cd8+ t-cell epitopes
05/09/2012EP1631281B1 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit
05/09/2012EP1492813B1 OX40R binding agents
05/09/2012EP1441589B1 Stable liquid pharmaceutical formulation of igg antibodies
05/09/2012EP1427830B1 Bv8 NUCLEIC ACIDS AND POLYPEPTIDES WITH MITOGENIC ACTIVITY
05/09/2012EP1379337B1 Generation of pharmaceutical agent particles using focused acoustic energy
05/09/2012CN1596248B Phenoxy amine compounds and compositions for delivering active agents
05/09/2012CN102449148A Ss-galactosidase derived from bacillus circulans
05/09/2012CN102449143A Compositions and methods comprising aspartyl-trna synthetases having non-canonical biological activities
05/09/2012CN102449140A Methods of inhibiting photoreceptor apoptosis
05/09/2012CN102448983A Fibromodulin peptide
05/09/2012CN102448982A Compositions and methods for modulating the activity of complement regulatory proteins on target cells
05/09/2012CN102448949A Heterocyclic compound and hematopoietic stem cell amplifier
05/09/2012CN102448485A Immunogenic composition and uses thereof
05/09/2012CN102448484A A method of regulating proliferation and differentiation of keratinocyes
05/09/2012CN102448483A Peptide compositions for oral care systems
05/09/2012CN102448482A Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
05/09/2012CN102448481A Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans
05/09/2012CN102448480A Composition for regulating autonomic nervous activity and method for regulating autonomic nerve
05/09/2012CN102448473A Use of serine protease inhibitors in the treatment of neutropenia
05/09/2012CN102448472A Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
05/09/2012CN102448442A Treatment of tissue adhesion
05/09/2012CN102443593A Preparation method for beta-lactamase inhibitory polypeptide and expression vector used therein
05/09/2012CN102443586A Protein for treating tumor
05/09/2012CN102443548A Method for producing gamma-carboxylated proteins
05/09/2012CN102443065A Preparation for specificity anticoagulant substance and application thereof
05/09/2012CN102443064A Thrombin activity based chimeric peptide with double targeting effects and application thereof
05/09/2012CN102441173A Preparation method of a drug release system with water-insoluble protein powder as drug carrier
05/09/2012CN102441172A High-purity prothrombin complex product freeze-drying stabilizer
05/09/2012CN102441161A Composite fat-soluble antioxidant
05/09/2012CN102441160A Thymosin alpha1 medicinal composition and preparation method thereof
05/09/2012CN102441159A Application of human polypeptide in preparation of immune regulator
05/09/2012CN102441158A Eye drop having Cecropins for pet and preparation method thereof
05/09/2012CN102441157A Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
05/09/2012CN102440968A More stable desmopressin (DDAVP) polypeptide drug freeze-dried powder injection
05/09/2012CN102440966A Preparation process research of exenatide slow-release preparation
05/09/2012CN102440964A Goserelin slow release microsphere preparation and preparation method thereof
05/09/2012CN102440959A Pidotimod liposome solid preparation
05/09/2012CN102440957A Terlipressin acetate nasal cavity spray and preparation method thereof
05/09/2012CN102440386A Full composite human body antioxidant
05/09/2012CN101928710B Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application
05/09/2012CN101891807B Canola protein isolate compositions
05/09/2012CN101691394B Method for solid phase synthesis of bitter gourd MC-JJ6 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ6 peptide analogs
05/09/2012CN101514229B Human interferon alpha derivative and polyethylene glycol modified substance thereof
1 ... 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 ... 3163